Recurrent breast relapses in a patient with acute lymphoblastic leukaemia following allogeneic bone marrow transplantation

Acta Haematologica
S SavaşanY Ravindranath

Abstract

Isolated extramedullary relapse is very rare after allogeneic bone marrow transplantation (BMT) in acute lymphoblastic leukaemia (ALL) and continues to be a therapeutic problem. We report recurrent breast relapses in a patient with ALL after allogeneic BMT. On both occasions, bone marrow cells were shown to be of donor origin and masses disappeared after systemic chemotherapy. Treatment of the isolated extramedullary relapse after allogeneic BMT is discussed.

Citations

Jul 12, 2008·Hematology·Merat Karbasian-EsfahaniLool Abebe
Aug 30, 2008·Pediatric Hematology and Oncology·K TodoS Todo
Dec 16, 2006·Leukemia & Lymphoma·Isabel Cunningham
Oct 27, 2006·Leukemia & Lymphoma·Isabel Cunningham
Jan 31, 2012·American Journal of Hematology·Isabel Cunningham
Dec 10, 2019·World Journal of Clinical Oncology·Omer SagerMurat Beyzadeoglu
Apr 13, 2012·Acta Radiologica·Alexey SurovJasmin Abbas
Dec 15, 2020·Critical Reviews in Oncology/hematology·Isabel Cunningham

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.